Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 15/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13956282 | 0.93 | MAOB (0.52) | MAOBHPGDMAOAMAPTALDH1A1 | |
| SCHEMBL13956334 | 0.92 | HPGD (0.47) | MAOBHPGDMAPTALDH1A1GAA | |
| SCHEMBL13971253 | 0.87 | ALDH1A1 (0.43) | HPGDMAPTALDH1A1GAAKDM4E | |
| SCHEMBL13785972 | 0.81 | MAOB (0.62) | MAOBMAOAMAPTALDH1A1GAA | |
| SCHEMBL13956302 | 0.78 | ALDH1A1 (0.48) | HPGDMAPTALDH1A1GAAKDM4E | |
| SCHEMBL13971161 | 0.78 | ALDH1A1 (0.44) | MAOBHPGDMAPTALDH1A1GAA | |
| SCHEMBL13785964 | 0.76 | MAOB (0.70) | MAOBHPGDMAOAMAPTHDAC8 | |
| SCHEMBL4733326 | 0.74 | MAOB (0.70) | MAOBMAOAMAPTALDH1A1GAA | |
| SCHEMBL4699500 | 0.74 | MAOB (0.65) | MAOBMAOAMAPTALDH1A1GAA | |
| SCHEMBL4699493 | 0.74 | MAOB (0.65) | MAOBMAOAMAPTALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090005321-A1 | Phenylazetidinone Derivatives | MICROBIA, INC. (US) | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005321-A1 | Phenylazetidinone Derivatives | TYR, AAAS, FANCD2 | MAOB 457/4885HPGD 57/4885MAOA 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.